Centiva Capital’s InspireMD NSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$30.9K Buy
44,123
+19,357
+78% +$20.5K ﹤0.01% 1666
2026
Q1
$40.4K Buy
+24,766
New +$42.2K ﹤0.01% 1507

Other funds holding NSPR

Centiva Capital's NSPR Position: Q2 2026 in Review

Centiva Capital increased its InspireMD (NSPR) stake by 78% in Q2 2026, buying an estimated $20.5K and bringing the position to 44,123 shares worth $30.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

Centiva Capital first reported a position in NSPR in Q1 2026 and has held it in 2 quarters since. The position peaked at $40.4K in Q1 2026. 37 funds tracked by Wall St. Rank hold NSPR as of Q2 2026.

  • Centiva Capital held 44,123 shares of InspireMD worth $30.9K as of Q2 2026.
  • Centiva Capital bought 19,357 InspireMD shares in Q2 2026, an estimated $20.5K.
  • InspireMD made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1666 holding.
  • Centiva Capital first reported a position in InspireMD in Q1 2026 and has held it in 2 quarters since.
  • Centiva Capital's InspireMD position peaked at $40.4K in Q1 2026.
  • 37 funds tracked by Wall St. Rank held InspireMD as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.